Shengjun Mao
Impact in
-
- Traditional Chinese Medicine Analysis
- Medicinal Plants and Neuroprotection
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Traditional Chinese Medicine Analysis 11
- Medicinal Plants and Neuroprotection 9
- Traditional Chinese Medicine Studies 4
-
- RNA Interference and Gene Delivery 6
- Metabolomics and Mass Spectrometry Studies 3
- Co-authors
- Qiantao Wang (7 shared papers)Shixiang Hou (11 shared papers)Dapeng Wei (5 shared papers)Hui Jin (9 shared papers)Liangke Zhang (6 shared papers)Xiangrong Song (4 shared papers)Yi Lü (1 shared paper)Yongxiang Zheng (2 shared papers)
- Journals
- International Journal of Pharmaceutics (7 papers)Journal of Hydrology (4 papers)Neuroscience (3 papers)Chemical and Pharmaceutical Bulletin (3 papers)Neuropharmacology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Shengjun Mao
56 papers receiving 747 citations
Peers
Comparison fields: 5 of 94
- Complementary and alternative medicine 152
- Biomaterials 161
- Pharmaceutical Science 70
- Pharmacology 77
- Neurology 65
Countries citing papers authored by Shengjun Mao
This map shows the geographic impact of Shengjun Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjun Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjun Mao more than expected).
Fields of papers citing papers by Shengjun Mao
This network shows the impact of papers produced by Shengjun Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjun Mao. The network helps show where Shengjun Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengjun Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 106 | |
| 2 | 2020 | 63 | |
| 3 | 2011 | 41 | |
| 4 | 2005 | 39 | |
| 5 | 2019 | 33 | |
| 6 | 2019 | 32 | |
| 7 | Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. | 2007 | 32 |
| 8 | 2021 | 31 | |
| 9 | 2021 | 27 | |
| 10 | 2017 | 26 | |
| 11 | 2022 | 25 | |
| 12 | 2017 | 23 | |
| 13 | 2009 | 21 | |
| 14 | 2013 | 20 | |
| 15 | 2014 | 19 | |
| 16 | 2022 | 18 | |
| 17 | 2007 | 18 | |
| 18 | 2022 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2017 | 11 |
About Shengjun Mao
Shengjun Mao is a scholar working on Complementary and alternative medicine, Molecular Biology, Pharmacology, Neurology and Physiology, having authored 58 papers that have together received 761 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (11 papers), Medicinal Plants and Neuroprotection (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), RNA Interference and Gene Delivery (6 papers), Pharmacological Effects of Natural Compounds (6 papers), Neuroscience and Neuropharmacology Research (4 papers), Traditional Chinese Medicine Studies (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Complementary and alternative medicine (152 citations), Biomaterials (161 citations), Pharmaceutical Science (70 citations), Pharmacology (77 citations) and Neurology (65 citations). Shengjun Mao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qiantao Wang, Shixiang Hou, Dapeng Wei, Hui Jin, Liangke Zhang, Xiangrong Song, Yi Lü, Yongxiang Zheng, Qi Liu and Yu Chen. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Hydrology, Neuroscience, Chemical and Pharmaceutical Bulletin and Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.